The controversy over patenting genes took a new twist in February, when a
patients group got in on the act. PXE International patented methods of treating
the debilitating genetic disease PXE based on the MRP6 gene. Mutations
in MRP6 are to blame for the disease. The group hopes that owning the
gene will allow it to accelerate research, control licence fees and prevent turf
wars between scientists.
More from New Scientist
Explore the latest news, articles and features
Humans
Ancient Egyptians may have built a massive dam near the Red Pyramid
News
Space
SpaceX rocket crashes into moon at 8700 kilometres per hour
News
Life
Should you stop using preventive flea treatments on your pets?
News
Technology
Most people prefer AI-written stories 鈥� and can’t tell when they are made by humans
News
Popular articles
Trending New Scientist articles